Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
Realcan Pharmaceutical Group Co FCF Yield % Explanation
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Realcan Pharmaceutical Group Co FCF Yield % Related Terms
Realcan Pharmaceutical Group Co FCF Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SZSE:002589 vs MCK, COR, CAH: FCF Yield % Comparison
For the Medical Distribution subindustry, Realcan Pharmaceutical Group Co's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Realcan Pharmaceutical Group Co FCF Yield % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Realcan Pharmaceutical Group Co's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Realcan Pharmaceutical Group Co's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Realcan Pharmaceutical Group Co (SZSE:002589) has a FCF Yield % of 0.57 as of Aug. 25, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Realcan Pharmaceutical Group Co and its competitors. According to the industry distribution chart, Realcan Pharmaceutical Group Co ranks #63 out of 118 companies in the Medical Distribution industry, placing it in the top 53.4%.
Is Realcan Pharmaceutical Group Co's FCF Yield % too high?
Realcan Pharmaceutical Group Co's current FCF Yield % is 0.57. The Medical Distribution industry median FCF Yield % is 1.10. Realcan Pharmaceutical Group Co's value of 0.57 is 48.2% below this industry median. Based on the distribution chart, Realcan Pharmaceutical Group Co ranks #63 out of 118 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Realcan Pharmaceutical Group Co has a GF Score™ of 53/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Realcan Pharmaceutical Group Co's FCF Yield % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Realcan Pharmaceutical Group Co ranks #63 out of 118 companies for FCF Yield %. This places Realcan Pharmaceutical Group Co in the lower half of its industry. The industry median FCF Yield % is 1.10. Realcan Pharmaceutical Group Co's value of 0.57 is 48.2% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Medical Distribution company?
The median FCF Yield % among Medical Distribution companies is 1.10, based on 118 companies in the industry. Companies in the top quartile (top 25%) have a FCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Realcan Pharmaceutical Group Co's current FCF Yield % of 0.57 is 48.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Realcan Pharmaceutical Group Co and its competitors. For the Medical Distribution industry, the median FCF Yield % is 1.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Realcan Pharmaceutical Group Co's current FCF Yield % is 0.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Realcan Pharmaceutical Group Co stock overvalued right now?
Based on GuruFocus' analysis, Realcan Pharmaceutical Group Co (SZSE:002589) is currently considered Modestly Overvalued. The stock's GF Value™ is ¥2.46, compared to a current price of ¥3.15 — trading 28% above its estimated fair value. The current FCF Yield % is 0.57 and 48.2% below the Medical Distribution industry median of 1.10. Realcan Pharmaceutical Group Co's overall GF Score™ is 53/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Realcan Pharmaceutical Group Co (SZSE:002589), the current FCF Yield % is 0.57 as of Aug. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Realcan Pharmaceutical Group Co (SZSE:002589) Overvalued in 2026?
Based on GuruFocus' analysis, Realcan Pharmaceutical Group Co stock appears to be overvalued.
The current stock price of ¥3.15 is trading 28% above its estimated GF Value™ of ¥2.46.
GuruFocus considers Realcan Pharmaceutical Group Co to be Modestly Overvalued.
Key valuation signals for SZSE:002589:
FCF Yield %: 0.57
GF Value™: ¥2.46 vs. price of ¥3.15 (28% above fair value)
Industry Position: 48.2% below the Medical Distribution median (#63 of 118)
No single metric tells the full story. See the SZSE:002589 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Realcan Pharmaceutical Group Co Ltd is a Chinese company engaged in direct pharmaceuticals distribution services. The company's main business is divided into the Drug, vaccine, medical device circulation service; Medical industry third-party logistics; Medical information service; Medical logistics service; Chinese medicine plate; Hospital management sector; Medical industry research and development production sector; and Medical industry financial sector.
53GF Score
Get the complete analysis for SZSE:002589
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SZSE:002589 has been successfully added to your 
